Humphreys Keith, Weingardt Kenneth R, Harris Alex H S
Veterans Affairs Health Care System and Stanford University School of Medicine, Palo Alto, California, USA.
Alcohol Clin Exp Res. 2007 Jun;31(6):988-95. doi: 10.1111/j.1530-0277.2007.00391.x. Epub 2007 Apr 11.
Many alcohol treatment outcome studies exclude some patients with particular problems, such as psychiatric disorders, noncompliance, and homelessness. Such criteria may increase the likelihood of a study being successfully conducted, but may also have the unintended consequence of reducing a study's ability to comply with National Institutes of Health guidelines for inclusion of racial minorities, women, and children in treatment research.
This paper examined this issue empirically using 5 prior studies of treatment systems enrolling over 100,000 alcohol patients. Widely used eligibility criteria in the alcohol treatment field typically exclude between one-fifth to one-third of patients from enrolling in research. Under several eligibility criteria, most notably those for drug use and social/residential instability, women and African-American patients are substantially more likely to be excluded than are men and non-African-American patients, respectively.
In designing treatment studies with many eligibility criteria, researchers may therefore inadvertently be thwarting their own good faith efforts to ensure that a range of vulnerable populations are able to participate in research. We analyze the implications of this dilemma for the generalizability of treatment results and for research design, and provide data that may help researchers working in different treatment systems estimate the impact of various eligibility criteria.
许多酒精治疗结果研究将一些有特殊问题的患者排除在外,如精神疾病、不依从和无家可归者。这样的标准可能会增加研究成功开展的可能性,但也可能产生意想不到的后果,即降低研究遵守美国国立卫生研究院关于在治疗研究中纳入少数族裔、女性和儿童的指导方针的能力。
本文通过对5项涉及超过100,000名酒精患者的治疗系统的先前研究,对这一问题进行了实证研究。酒精治疗领域广泛使用的资格标准通常会将五分之一至三分之一的患者排除在研究之外。在几项资格标准下,最显著的是药物使用和社会/居住不稳定标准,女性和非裔美国患者分别比男性和非非裔美国患者更有可能被排除在外。
因此,在设计具有许多资格标准的治疗研究时,研究人员可能会无意中阻碍他们自己为确保一系列弱势群体能够参与研究而做出的真诚努力。我们分析了这一困境对治疗结果的普遍性和研究设计的影响,并提供了数据,可能有助于在不同治疗系统中工作的研究人员估计各种资格标准的影响。